PCMC
ABOS icon

Planning Capital Management Corporation’s Acumen Pharmaceuticals ABOS Stock Holding History

Planning Capital Management Corporation’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13 Hold
5
– – ﹤0.01% 769
2024
Q2 		$13 Buy
+5
New +$16 ﹤0.01% 712

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Planning Capital Management Corporation's ABOS Position: Q3 2024 in Review

Planning Capital Management Corporation held its Acumen Pharmaceuticals (ABOS) position steady in Q3 2024 at 5 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Planning Capital Management Corporation first reported a position in ABOS in Q2 2024 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold ABOS as of Q3 2024.

  • Planning Capital Management Corporation held 5 shares of Acumen Pharmaceuticals worth $13 as of Q3 2024.
  • Planning Capital Management Corporation left its Acumen Pharmaceuticals share count unchanged in Q3 2024.
  • Acumen Pharmaceuticals made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #769 holding.
  • Planning Capital Management Corporation first reported a position in Acumen Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.